Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Standard BioTools Inc. (LAB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Standard BioTools Inc. (LAB), most recent 12 months reported: revenue $84.6M, net income $84.91M, free cash flow -$82.58M. Latest balance sheet on file: liquid cash $476.72M, total debt $299K, net cash $476.42M. From SEC filings. Others in Pharmaceutical Preparations: Xencor, Inc · Septerna, Inc. · AGIOS PHARMACEUTICALS, INC. · Verastem, Inc. · ADC Therapeutics SA · KURA ONCOLOGY, INC. · Assembly Biosciences, Inc. · Viridian Therapeutics, Inc./DE

Stock screener

Watchlist